ES499034A0 - Un procedimiento para la preparacion de 2-(2-(1,4-benzodio- xanil))-2-imidazolina - Google Patents

Un procedimiento para la preparacion de 2-(2-(1,4-benzodio- xanil))-2-imidazolina

Info

Publication number
ES499034A0
ES499034A0 ES499034A ES499034A ES499034A0 ES 499034 A0 ES499034 A0 ES 499034A0 ES 499034 A ES499034 A ES 499034A ES 499034 A ES499034 A ES 499034A ES 499034 A0 ES499034 A0 ES 499034A0
Authority
ES
Spain
Prior art keywords
benzodium
xanil
imidazoline
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES499034A
Other languages
English (en)
Spanish (es)
Other versions
ES8202553A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt and Colman Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt and Colman Products Ltd filed Critical Reckitt and Colman Products Ltd
Publication of ES8202553A1 publication Critical patent/ES8202553A1/es
Publication of ES499034A0 publication Critical patent/ES499034A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES499034A 1980-02-04 1981-02-02 Un procedimiento para la preparacion de 2-(2-(1,4-benzodio- xanil))-2-imidazolina Granted ES499034A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8003636 1980-02-04

Publications (2)

Publication Number Publication Date
ES8202553A1 ES8202553A1 (es) 1982-02-01
ES499034A0 true ES499034A0 (es) 1982-02-01

Family

ID=10511105

Family Applications (1)

Application Number Title Priority Date Filing Date
ES499034A Granted ES499034A0 (es) 1980-02-04 1981-02-02 Un procedimiento para la preparacion de 2-(2-(1,4-benzodio- xanil))-2-imidazolina

Country Status (26)

Country Link
US (1) US4818764A (en])
EP (1) EP0033655B1 (en])
JP (1) JPS56122378A (en])
AR (1) AR225794A1 (en])
AT (1) ATE7228T1 (en])
AU (1) AU535320B2 (en])
CA (1) CA1156241A (en])
CS (1) CS254956B2 (en])
DD (1) DD155991A5 (en])
DE (1) DE3163256D1 (en])
DK (1) DK160092C (en])
ES (1) ES499034A0 (en])
FI (1) FI67543C (en])
GB (1) GB2068376B (en])
GR (1) GR73853B (en])
HU (1) HU187295B (en])
IE (1) IE51736B1 (en])
IL (1) IL62039A (en])
NO (1) NO154882C (en])
NZ (1) NZ196162A (en])
PH (1) PH16249A (en])
PL (1) PL128368B1 (en])
PT (1) PT72435B (en])
SU (1) SU1128837A3 (en])
ZA (1) ZA81666B (en])
ZW (1) ZW2381A1 (en])

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199469A (en) * 1981-01-30 1984-03-16 Reckitt & Colmann Prod Ltd Benzodioxanyl-2-imidazoline derivatives and pharmaceutical compositions
US4436914A (en) 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
NZ203680A (en) * 1982-04-17 1985-08-16 Reckitt & Colmann Prod Ltd Imidazolines and pharmaceutical compositions
FR2527208B1 (fr) * 1982-05-19 1985-07-19 Inst Nat Sante Rech Med Isomeres optiques de la (benzodioxanne-1,4 yl-2)-2d-2 imidazoline, leur preparation et leur application en therapeutique
ATE23337T1 (de) * 1982-12-23 1986-11-15 Ici America Inc Chromanverbindungen.
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
GB8720600D0 (en) * 1987-09-02 1987-10-07 Saad Al Damluji Pharmaceutical compositions
US5240930A (en) * 1987-09-02 1993-08-31 National Research Development Corporation Pharmaceutical compositions for treatment of depression and low blood pressure
FR2698789B1 (fr) * 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
FR2700113B1 (fr) * 1993-01-07 1995-03-24 Pf Medicament Utilisation de l'Idazoxan et ses dérivés pour la fabrication de médicaments destinés au traitement des maladies neurodégénératives et en particulier l'évolution de la maladie d'Alzheimer.
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2795727B1 (fr) * 1999-06-29 2001-09-21 Pf Medicament Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite
US20010049368A1 (en) * 2000-02-29 2001-12-06 Reines Scott A. Method for treating or preventing depression
FR2861299B1 (fr) * 2003-10-28 2006-01-27 Pf Medicament Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
US7595335B2 (en) * 2003-10-28 2009-09-29 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
CN119053573A (zh) * 2022-02-16 2024-11-29 人类生物科学股份有限公司 氘代咪唑克生及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2641601A (en) * 1950-11-24 1953-06-09 Hoffmann La Roche Furans and method of preparation
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
DE2862340D1 (en) * 1978-02-01 1983-11-24 Wellcome Found Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4302469A (en) * 1980-09-10 1981-11-24 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
US4315021A (en) * 1980-12-03 1982-02-09 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles
US4301171A (en) * 1980-12-03 1981-11-17 Syntex (U.S.A.) Inc. 2-(1,4-Benzodioxan-2-ylalkyl)benzimidazoles useful as anti-depressants
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Also Published As

Publication number Publication date
ES8202553A1 (es) 1982-02-01
AU535320B2 (en) 1984-03-15
PT72435A (en) 1981-03-01
GR73853B (en]) 1984-05-07
US4818764A (en) 1989-04-04
ZW2381A1 (en) 1981-06-24
JPH0231077B2 (en]) 1990-07-11
ATE7228T1 (de) 1984-05-15
DE3163256D1 (en) 1984-05-30
ZA81666B (en) 1982-04-28
CS73881A2 (en) 1987-07-16
AR225794A1 (es) 1982-04-30
HU187295B (en) 1985-12-28
DK45081A (da) 1981-08-05
IE810199L (en) 1981-08-04
SU1128837A3 (ru) 1984-12-07
IL62039A (en) 1985-01-31
IL62039A0 (en) 1981-03-31
EP0033655A3 (en) 1981-11-25
EP0033655B1 (en) 1984-04-25
FI810288L (fi) 1981-08-05
IE51736B1 (en) 1987-03-18
GB2068376A (en) 1981-08-12
AU6675881A (en) 1981-08-13
EP0033655A2 (en) 1981-08-12
JPS56122378A (en) 1981-09-25
NO154882B (no) 1986-09-29
DD155991A5 (de) 1982-07-21
FI67543C (fi) 1985-04-10
PL229488A1 (en]) 1981-10-16
PT72435B (pt) 1982-01-29
NO154882C (no) 1987-01-07
CA1156241A (en) 1983-11-01
CS254956B2 (en) 1988-02-15
DK160092B (da) 1991-01-28
GB2068376B (en) 1983-06-22
PH16249A (en) 1983-08-16
PL128368B1 (en) 1984-01-31
NZ196162A (en) 1983-06-17
FI67543B (fi) 1984-12-31
DK160092C (da) 1991-06-24
NO810351L (no) 1981-08-05

Similar Documents

Publication Publication Date Title
ES506661A0 (es) Un procedimiento para la preparacion de nuevos derivados de la sacarosa industrialmente utiles.
ES514868A0 (es) "un procedimiento para la preparacion de un derivado de tiazol".
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
AR230834A1 (es) Un procedimiento para la preparacion de oxazolidin-2,4-dionas 5-sustituidas hiplogicemicas
ES512076A0 (es) "un procedimiento para la preparacion de piridin- y piracin-derivados".
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
AR225794A1 (es) Un procedimiento para la preparacion de 2-(2-(1,4-benzodioxanil))-2-imidazolina
ES507508A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES515159A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES504121A0 (es) Un procedimiento para la preparacion de imidazoles antiinflamaticos.
ES510996A0 (es) "un procedimiento para preparar compuestos de cefem".
ES511941A0 (es) "un procedimiento para la polimerizacion de un compuesto de eterglicidilico".
ES505345A0 (es) Un procedimiento para la preparacion de 1,1,1',1'-tetraoxidode penicilanato de penicilanoiloximetilo
AR229957A1 (es) Procedimiento para la preparacion de un derivado de 2-(2-(1,4-benzodiozanil))-2-i midazolima
ES502153A0 (es) Un procedimiento para la preparacion de compuestos n-acil-n- (cicloalquil) aminoacidos.
ES507918A0 (es) Un procedimiento para la preparacion de benzamitas sustituidas.
ES505019A0 (es) Un procedimiento para la preparacion de compuestos
ES527277A0 (es) Un procedimiento para obtener compuestos de 2'-o-acil-, 3'-o-acil-, 2',3'-di-o-acil- y 2',3',5'-tri-o-acil-2-b-d-ribofuranosilselenazol-4-carboxamida
ES510286A0 (es) "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas".
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES508152A0 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
ES505433A0 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES497342A0 (es) Un procedimiento para la preparacion de un compuesto de biu-ret 1,1,3,5-sustituido

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991016